The Effect of Bevacizumab on Peripheral Retinal Changes as Imaged by Wide-Field Fluorescein Angiography in Diabetic Macular Oedema
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 21 Nov 2021 Status changed from recruiting to completed.
- 05 Apr 2014 New trial record